BioCentury
ARTICLE | Clinical News

Remimazolam: Phase III started

April 13, 2015 7:00 AM UTC

Paion began a double-blind, placebo-controlled, U.S. Phase III trial to compare IV remimazolam vs. midazolam in about 460 patients undergoing colonoscopy. Patients will receive 5 mg remimazolam for in...